nodes	percent_of_prediction	percent_of_DWPC	metapath
Pseudoephedrine—IL2—epithelium—cervical cancer	0.0315	0.0828	CbGeAlD
Pseudoephedrine—IL2—uterine cervix—cervical cancer	0.0313	0.0821	CbGeAlD
Pseudoephedrine—IL2—renal system—cervical cancer	0.0293	0.0768	CbGeAlD
Pseudoephedrine—IL2—uterus—cervical cancer	0.0261	0.0685	CbGeAlD
Pseudoephedrine—IL2—female reproductive system—cervical cancer	0.0234	0.0615	CbGeAlD
Pseudoephedrine—NFATC1—female gonad—cervical cancer	0.0233	0.0612	CbGeAlD
Pseudoephedrine—TNF—vagina—cervical cancer	0.0221	0.0581	CbGeAlD
Pseudoephedrine—IL2—female gonad—cervical cancer	0.0213	0.056	CbGeAlD
Pseudoephedrine—NFATC1—lymph node—cervical cancer	0.015	0.0394	CbGeAlD
Pseudoephedrine—TNF—lymph node—cervical cancer	0.0143	0.0376	CbGeAlD
Pseudoephedrine—IL2—lymph node—cervical cancer	0.0137	0.036	CbGeAlD
Pseudoephedrine—SLC6A2—decidua—cervical cancer	0.00635	0.0167	CbGeAlD
Pseudoephedrine—ADRA1A—epithelium—cervical cancer	0.00625	0.0164	CbGeAlD
Pseudoephedrine—MAOA—uterine cervix—cervical cancer	0.00614	0.0161	CbGeAlD
Pseudoephedrine—ADRB1—female reproductive system—cervical cancer	0.00587	0.0154	CbGeAlD
Pseudoephedrine—MAOA—decidua—cervical cancer	0.00585	0.0154	CbGeAlD
Pseudoephedrine—ADRA1A—renal system—cervical cancer	0.0058	0.0152	CbGeAlD
Pseudoephedrine—MAOA—renal system—cervical cancer	0.00575	0.0151	CbGeAlD
Pseudoephedrine—SLC6A4—female reproductive system—cervical cancer	0.00567	0.0149	CbGeAlD
Pseudoephedrine—MAOA—endometrium—cervical cancer	0.00556	0.0146	CbGeAlD
Pseudoephedrine—MAOA—mammalian vulva—cervical cancer	0.00537	0.0141	CbGeAlD
Pseudoephedrine—MAOA—uterus—cervical cancer	0.00512	0.0134	CbGeAlD
Pseudoephedrine—SLC6A2—female reproductive system—cervical cancer	0.00499	0.0131	CbGeAlD
Pseudoephedrine—ADRA2A—uterine cervix—cervical cancer	0.00471	0.0124	CbGeAlD
Pseudoephedrine—MAOA—female reproductive system—cervical cancer	0.0046	0.0121	CbGeAlD
Pseudoephedrine—ADRA2A—decidua—cervical cancer	0.00449	0.0118	CbGeAlD
Pseudoephedrine—ADRA2A—endometrium—cervical cancer	0.00426	0.0112	CbGeAlD
Pseudoephedrine—MAOA—female gonad—cervical cancer	0.00419	0.011	CbGeAlD
Pseudoephedrine—MAOA—vagina—cervical cancer	0.00416	0.0109	CbGeAlD
Pseudoephedrine—ADRA2A—mammalian vulva—cervical cancer	0.00412	0.0108	CbGeAlD
Pseudoephedrine—ADRA2A—uterus—cervical cancer	0.00393	0.0103	CbGeAlD
Pseudoephedrine—ADRA2A—female reproductive system—cervical cancer	0.00353	0.00927	CbGeAlD
Pseudoephedrine—CYP2D6—renal system—cervical cancer	0.00341	0.00897	CbGeAlD
Pseudoephedrine—ADRA2A—female gonad—cervical cancer	0.00321	0.00844	CbGeAlD
Pseudoephedrine—ADRA2A—vagina—cervical cancer	0.00319	0.00839	CbGeAlD
Pseudoephedrine—SLC6A2—lymph node—cervical cancer	0.00292	0.00767	CbGeAlD
Pseudoephedrine—CYP2D6—female reproductive system—cervical cancer	0.00273	0.00718	CbGeAlD
Pseudoephedrine—MAOA—lymph node—cervical cancer	0.00269	0.00707	CbGeAlD
Pseudoephedrine—CYP2D6—female gonad—cervical cancer	0.00249	0.00654	CbGeAlD
Pseudoephedrine—ADRA2A—lymph node—cervical cancer	0.00207	0.00542	CbGeAlD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—EGFR—cervical cancer	0.00129	0.00208	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—CASP8—cervical cancer	0.00128	0.00207	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CASP8—cervical cancer	0.00128	0.00207	CbGpPWpGaD
Pseudoephedrine—NFATC1—RNF mutants show enhanced WNT signaling and proliferation—CTNNB1—cervical cancer	0.00128	0.00206	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—CTNNB1—cervical cancer	0.00127	0.00205	CbGpPWpGaD
Pseudoephedrine—TNF—Caspase Cascade in Apoptosis—CASP3—cervical cancer	0.00126	0.00204	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00125	0.00202	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00124	0.00201	CbGpPWpGaD
Pseudoephedrine—NFATC1—Fc epsilon receptor (FCERI) signaling—EGFR—cervical cancer	0.00124	0.002	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP8—cervical cancer	0.00122	0.00197	CbGpPWpGaD
Pseudoephedrine—IL2—Spinal Cord Injury—TP53—cervical cancer	0.00121	0.00196	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—SERPIND1—cervical cancer	0.00119	0.00192	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GP6—cervical cancer	0.00119	0.00192	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by WNT in cancer—CTNNB1—cervical cancer	0.00119	0.00192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 signaling events—EGFR—cervical cancer	0.00117	0.00189	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—TAAR6—cervical cancer	0.00117	0.00189	CbGpPWpGaD
Pseudoephedrine—ADRB2—Arf6 trafficking events—CTNNB1—cervical cancer	0.00117	0.00189	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00116	0.00187	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—TAAR6—cervical cancer	0.00114	0.00185	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor Pathway—EGFR—cervical cancer	0.00114	0.00185	CbGpPWpGaD
Pseudoephedrine—TNF—Aryl Hydrocarbon Receptor—EGFR—cervical cancer	0.00114	0.00185	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—CASP8—cervical cancer	0.00114	0.00183	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—WNT5A—cervical cancer	0.00113	0.00183	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TAAR6—cervical cancer	0.00113	0.00183	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—WNT5A—cervical cancer	0.00113	0.00182	CbGpPWpGaD
Pseudoephedrine—TNF—Amyotrophic lateral sclerosis (ALS)—TP53—cervical cancer	0.00112	0.00181	CbGpPWpGaD
Pseudoephedrine—TNF—TGF-beta Receptor Signaling—STAT3—cervical cancer	0.00111	0.00179	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00108	0.00175	CbGpPWpGaD
Pseudoephedrine—NFATC1—MAPK Signaling Pathway—TP53—cervical cancer	0.00108	0.00175	CbGpPWpGaD
Pseudoephedrine—TNF—Toll-like Receptor Signaling Pathway—CASP8—cervical cancer	0.00105	0.00169	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—WNT2—cervical cancer	0.00104	0.00168	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—GP5—cervical cancer	0.00104	0.00168	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00103	0.00166	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—MTOR—cervical cancer	0.001	0.00162	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling by Wnt—CTNNB1—cervical cancer	0.000978	0.00158	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—FGFR3—cervical cancer	0.000972	0.00157	CbGpPWpGaD
Pseudoephedrine—TNF—Allograft Rejection—CASP3—cervical cancer	0.000971	0.00157	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—CASP3—cervical cancer	0.000971	0.00157	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DPB1—cervical cancer	0.000949	0.00153	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—TAAR6—cervical cancer	0.000947	0.00153	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP3—cervical cancer	0.000924	0.00149	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—AKAP13—cervical cancer	0.000916	0.00148	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—WNT2—cervical cancer	0.000913	0.00147	CbGpPWpGaD
Pseudoephedrine—TNF—Signaling events mediated by HDAC Class I—STAT3—cervical cancer	0.000899	0.00145	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—WNT2—cervical cancer	0.000893	0.00144	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—cervical cancer	0.000891	0.00144	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—WNT2—cervical cancer	0.000882	0.00142	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—TAAR6—cervical cancer	0.00088	0.00142	CbGpPWpGaD
Pseudoephedrine—TNF—TNF alpha Signaling Pathway—CASP3—cervical cancer	0.000859	0.00139	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CASP8—cervical cancer	0.000831	0.00134	CbGpPWpGaD
Pseudoephedrine—TNF—Regulation of toll-like receptor signaling pathway—CASP8—cervical cancer	0.000816	0.00132	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DPB1—cervical cancer	0.000803	0.0013	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—MTOR—cervical cancer	0.000803	0.0013	CbGpPWpGaD
Pseudoephedrine—IL2—Cytokine Signaling in Immune system—STAT3—cervical cancer	0.000797	0.00129	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—WNT5A—cervical cancer	0.000791	0.00128	CbGpPWpGaD
Pseudoephedrine—TNF—MicroRNAs in cardiomyocyte hypertrophy—STAT3—cervical cancer	0.000777	0.00125	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—AKAP13—cervical cancer	0.000775	0.00125	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP8—cervical cancer	0.000748	0.00121	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—HLA-DQB1—cervical cancer	0.000741	0.0012	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—WNT2—cervical cancer	0.000739	0.00119	CbGpPWpGaD
Pseudoephedrine—TNF—Folate Metabolism—TP53—cervical cancer	0.000719	0.00116	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—CASP3—cervical cancer	0.000704	0.00114	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—CASP8—cervical cancer	0.000702	0.00113	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR ligand binding—WNT5A—cervical cancer	0.000692	0.00112	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD8A—cervical cancer	0.000692	0.00112	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—WNT2—cervical cancer	0.000687	0.00111	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—MTOR—cervical cancer	0.000684	0.0011	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CD4—cervical cancer	0.000682	0.0011	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR ligand binding—WNT5A—cervical cancer	0.000677	0.00109	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—WNT5A—cervical cancer	0.000669	0.00108	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—TAAR6—cervical cancer	0.000661	0.00107	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000652	0.00105	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—HES1—cervical cancer	0.00065	0.00105	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—TAAR6—cervical cancer	0.000647	0.00104	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000633	0.00102	CbGpPWpGaD
Pseudoephedrine—SLC6A4—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000629	0.00102	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—CTNNB1—cervical cancer	0.000628	0.00101	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—HLA-DQB1—cervical cancer	0.000627	0.00101	CbGpPWpGaD
Pseudoephedrine—TNF—Alzheimers Disease—TP53—cervical cancer	0.000622	0.00101	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—CTNNB1—cervical cancer	0.000606	0.000979	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—TAAR6—cervical cancer	0.0006	0.00097	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—cervical cancer	0.000593	0.000957	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—TAAR6—cervical cancer	0.000587	0.000948	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD8A—cervical cancer	0.000585	0.000945	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MTHFR—cervical cancer	0.000571	0.000922	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—TERT—cervical cancer	0.000569	0.000919	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CASP3—cervical cancer	0.000566	0.000914	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—FGFR3—cervical cancer	0.000566	0.000914	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000563	0.00091	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR ligand binding—WNT5A—cervical cancer	0.00056	0.000904	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOTCH2—cervical cancer	0.000555	0.000896	CbGpPWpGaD
Pseudoephedrine—TNF—Adipogenesis—STAT3—cervical cancer	0.000548	0.000884	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—CTNNB1—cervical cancer	0.000546	0.000881	CbGpPWpGaD
Pseudoephedrine—TNF—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000543	0.000877	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—EGFR—cervical cancer	0.000538	0.000868	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—TAAR6—cervical cancer	0.000535	0.000864	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.000535	0.000863	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—CASP3—cervical cancer	0.000531	0.000857	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—FGFR3—cervical cancer	0.000522	0.000844	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR ligand binding—WNT5A—cervical cancer	0.00052	0.00084	CbGpPWpGaD
Pseudoephedrine—MAOA—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.000515	0.000832	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—TAAR6—cervical cancer	0.000497	0.000803	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—NOTCH1—cervical cancer	0.000491	0.000792	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—TAAR6—cervical cancer	0.000486	0.000784	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CASP8—cervical cancer	0.000484	0.000781	CbGpPWpGaD
Pseudoephedrine—NFATC1—Innate Immune System—EGFR—cervical cancer	0.00048	0.000775	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000479	0.000774	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—FGFR3—cervical cancer	0.000479	0.000773	CbGpPWpGaD
Pseudoephedrine—ADRA1A—AMPK Signaling—TP53—cervical cancer	0.000473	0.000764	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOTCH2—cervical cancer	0.000469	0.000758	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—WNT2—cervical cancer	0.000469	0.000757	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000462	0.000746	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—WNT2—cervical cancer	0.000458	0.00074	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—HES1—cervical cancer	0.000455	0.000735	CbGpPWpGaD
Pseudoephedrine—ADRB1—GPCR downstream signaling—AKAP13—cervical cancer	0.000453	0.000732	CbGpPWpGaD
Pseudoephedrine—TNF—Spinal Cord Injury—TP53—cervical cancer	0.000452	0.000729	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—TAAR6—cervical cancer	0.000451	0.000729	CbGpPWpGaD
Pseudoephedrine—ADRB2—GPCR downstream signaling—AKAP13—cervical cancer	0.000443	0.000716	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—HES1—cervical cancer	0.000431	0.000695	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—AKAP13—cervical cancer	0.000411	0.000664	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CASP8—cervical cancer	0.000409	0.000661	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—EGFR—cervical cancer	0.000405	0.000655	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—AKAP13—cervical cancer	0.000403	0.00065	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TERT—cervical cancer	0.000399	0.000644	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—MTOR—cervical cancer	0.000398	0.000643	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CD4—cervical cancer	0.000397	0.000642	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—HES1—cervical cancer	0.000385	0.000621	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—WNT2—cervical cancer	0.000379	0.000612	CbGpPWpGaD
Pseudoephedrine—IL2—Hemostasis—TP53—cervical cancer	0.000379	0.000612	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—MTOR—cervical cancer	0.000368	0.000594	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CD4—cervical cancer	0.000367	0.000592	CbGpPWpGaD
Pseudoephedrine—ADRA1A—GPCR downstream signaling—AKAP13—cervical cancer	0.000367	0.000592	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000366	0.000591	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—FGFR3—cervical cancer	0.000366	0.000591	CbGpPWpGaD
Pseudoephedrine—TNF—Apoptosis—TP53—cervical cancer	0.000363	0.000586	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—WNT5A—cervical cancer	0.000355	0.000574	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TAAR6—cervical cancer	0.000355	0.000573	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—CTNNB1—cervical cancer	0.000353	0.00057	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—WNT2—cervical cancer	0.000352	0.000569	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—CA9—cervical cancer	0.000352	0.000568	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—WNT5A—cervical cancer	0.000347	0.000561	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TAAR6—cervical cancer	0.000347	0.00056	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—NOTCH1—cervical cancer	0.000343	0.000555	CbGpPWpGaD
Pseudoephedrine—SLC6A4—Circadian rythm related genes—TP53—cervical cancer	0.000341	0.000551	CbGpPWpGaD
Pseudoephedrine—ADRA2A—GPCR downstream signaling—AKAP13—cervical cancer	0.000341	0.00055	CbGpPWpGaD
Pseudoephedrine—TNF—MAPK Signaling Pathway—TP53—cervical cancer	0.00034	0.00055	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TERT—cervical cancer	0.000337	0.000545	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—MTOR—cervical cancer	0.000337	0.000544	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CD4—cervical cancer	0.000336	0.000543	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—AKAP13—cervical cancer	0.000333	0.000538	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—CTNNB1—cervical cancer	0.000326	0.000526	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—NOTCH1—cervical cancer	0.000325	0.000525	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—FGFR3—cervical cancer	0.000309	0.0005	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—AKAP13—cervical cancer	0.000309	0.0005	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—STAT3—cervical cancer	0.000308	0.000497	CbGpPWpGaD
Pseudoephedrine—TNF—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000307	0.000496	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—CTNNB1—cervical cancer	0.000299	0.000482	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—NOTCH1—cervical cancer	0.000291	0.000469	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000287	0.000464	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000287	0.000463	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—STAT3—cervical cancer	0.000284	0.000459	CbGpPWpGaD
Pseudoephedrine—NFATC1—Immune System—EGFR—cervical cancer	0.00028	0.000452	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—WNT2—cervical cancer	0.000277	0.000447	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—WNT2—cervical cancer	0.000271	0.000437	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—WNT5A—cervical cancer	0.000267	0.000431	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TAAR6—cervical cancer	0.000267	0.000431	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—STAT3—cervical cancer	0.00026	0.00042	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling by GPCR—EGFR—cervical cancer	0.000259	0.000418	CbGpPWpGaD
Pseudoephedrine—NFATC1—Disease—EGFR—cervical cancer	0.000258	0.000417	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—MTOR—cervical cancer	0.000257	0.000416	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—AKAP13—cervical cancer	0.000243	0.000393	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—AKAP13—cervical cancer	0.000238	0.000384	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CASP3—cervical cancer	0.000237	0.000382	CbGpPWpGaD
Pseudoephedrine—IL2—Immune System—EGFR—cervical cancer	0.000237	0.000382	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—CA9—cervical cancer	0.000235	0.00038	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—CTNNB1—cervical cancer	0.000228	0.000368	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000227	0.000367	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000224	0.000362	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—MTOR—cervical cancer	0.000218	0.000352	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—CTNNB1—cervical cancer	0.000216	0.000349	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—WNT5A—cervical cancer	0.00021	0.000339	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—WNT2—cervical cancer	0.000208	0.000336	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—WNT5A—cervical cancer	0.000205	0.000331	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CASP3—cervical cancer	0.0002	0.000323	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—STAT3—cervical cancer	0.000199	0.000321	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000197	0.000318	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—CTNNB1—cervical cancer	0.000193	0.000312	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—STAT3—cervical cancer	0.000188	0.000304	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—AKAP13—cervical cancer	0.000183	0.000295	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—EGFR—cervical cancer	0.000181	0.000292	CbGpPWpGaD
Pseudoephedrine—TNF—Developmental Biology—EGFR—cervical cancer	0.000171	0.000276	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.00017	0.000274	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—STAT3—cervical cancer	0.000168	0.000272	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000158	0.000255	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—CA9—cervical cancer	0.000153	0.000247	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—EGFR—cervical cancer	0.000153	0.000247	CbGpPWpGaD
Pseudoephedrine—NFATC1—Signaling Pathways—TP53—cervical cancer	0.000152	0.000245	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.000147	0.000238	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH2—cervical cancer	0.000144	0.000233	CbGpPWpGaD
Pseudoephedrine—MAOA—Metabolism—MTHFR—cervical cancer	0.000143	0.000231	CbGpPWpGaD
Pseudoephedrine—IL2—Signaling Pathways—TP53—cervical cancer	0.000128	0.000207	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—HES1—cervical cancer	0.000121	0.000195	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000119	0.000192	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—HES1—cervical cancer	0.000118	0.000191	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	0.000111	0.000179	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TERT—cervical cancer	0.000106	0.000171	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TERT—cervical cancer	0.000104	0.000167	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—HES1—cervical cancer	9.77e-05	0.000158	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—FGFR3—cervical cancer	9.71e-05	0.000157	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Metabolism—MTHFR—cervical cancer	9.54e-05	0.000154	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—FGFR3—cervical cancer	9.5e-05	0.000153	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	9.12e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—HES1—cervical cancer	9.08e-05	0.000147	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Hemostasis—TP53—cervical cancer	8.93e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—NOTCH1—cervical cancer	8.92e-05	0.000144	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TERT—cervical cancer	8.56e-05	0.000138	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling by GPCR—EGFR—cervical cancer	8.12e-05	0.000131	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TERT—cervical cancer	7.95e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling by GPCR—EGFR—cervical cancer	7.95e-05	0.000128	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	7.86e-05	0.000127	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	7.38e-05	0.000119	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	7.3e-05	0.000118	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	6.85e-05	0.000111	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—MTOR—cervical cancer	6.83e-05	0.00011	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—MTOR—cervical cancer	6.68e-05	0.000108	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	6.57e-05	0.000106	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CASP3—cervical cancer	6.28e-05	0.000101	CbGpPWpGaD
Pseudoephedrine—CYP2D6—Metabolism—MTHFR—cervical cancer	6.22e-05	0.0001	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CASP3—cervical cancer	6.15e-05	9.92e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	6.11e-05	9.86e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	6.06e-05	9.78e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—CTNNB1—cervical cancer	5.92e-05	9.57e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	5.53e-05	8.93e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—STAT3—cervical cancer	5.28e-05	8.52e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—STAT3—cervical cancer	5.16e-05	8.34e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	5.14e-05	8.29e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	5.08e-05	8.21e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	4.9e-05	7.91e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—EGFR—cervical cancer	4.8e-05	7.75e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	4.72e-05	7.63e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—EGFR—cervical cancer	4.69e-05	7.58e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	4.55e-05	7.35e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	4.27e-05	6.9e-05	CbGpPWpGaD
Pseudoephedrine—ADRB1—Signaling Pathways—TP53—cervical cancer	4.03e-05	6.51e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	3.97e-05	6.41e-05	CbGpPWpGaD
Pseudoephedrine—ADRB2—Signaling Pathways—TP53—cervical cancer	3.94e-05	6.36e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	3.88e-05	6.27e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	3.61e-05	5.82e-05	CbGpPWpGaD
Pseudoephedrine—ADRA1A—Signaling Pathways—TP53—cervical cancer	3.26e-05	5.26e-05	CbGpPWpGaD
Pseudoephedrine—ADRA2A—Signaling Pathways—TP53—cervical cancer	3.03e-05	4.89e-05	CbGpPWpGaD
